A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 517,565 shares of JNJ stock, worth $83.5 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
517,565
Previous 548,349 5.61%
Holding current value
$83.5 Million
Previous $86.7 Million 12.79%
% of portfolio
0.34%
Previous 0.4%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$144.38 - $157.78 $4.44 Million - $4.86 Million
-30,784 Reduced 5.61%
517,565 $75.6 Million
Q1 2024

May 09, 2024

BUY
$155.22 - $162.74 $75.5 Million - $79.2 Million
486,622 Added 788.35%
548,349 $86.7 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $38.1 Million - $41.6 Million
-261,854 Reduced 80.92%
61,727 $9.68 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $11.4 Million - $12.8 Million
73,229 Added 29.25%
323,581 $50.4 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $70.4 Million - $75.8 Million
-456,282 Reduced 64.57%
250,352 $41.4 Million
Q1 2023

May 09, 2023

SELL
$151.05 - $180.26 $22.1 Million - $26.4 Million
-146,259 Reduced 17.15%
706,634 $110 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $101 Million - $114 Million
633,486 Added 288.73%
852,893 $151 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $6.56 Million - $7.31 Million
-40,692 Reduced 15.64%
219,407 $35.8 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $15.6 Million - $17.2 Million
-92,688 Reduced 26.27%
260,099 $46.2 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $16.4 Million - $18.7 Million
-103,920 Reduced 22.75%
352,787 $62.5 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $39.7 Million - $44.1 Million
-254,717 Reduced 35.8%
456,707 $78.1 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $5.12 Million - $5.69 Million
-31,692 Reduced 4.26%
711,424 $115 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $5.26 Million - $5.64 Million
-32,986 Reduced 4.25%
743,116 $122 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $6.43 Million - $7.16 Million
-42,028 Reduced 5.14%
776,102 $128 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $35.3 Million - $40.5 Million
257,455 Added 45.92%
818,130 $129 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $17 Million - $18.6 Million
121,227 Added 27.59%
560,675 $83.5 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $29.3 Million - $35.3 Million
227,217 Added 107.06%
439,448 $61.8 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $31.7 Million - $43.9 Million
-284,860 Reduced 57.31%
212,231 $27.8 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $19.9 Million - $22.8 Million
-155,768 Reduced 23.86%
497,091 $72.5 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $18.7 Million - $21 Million
147,603 Added 29.21%
652,859 $84.5 Million
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $12.9 Million - $14.2 Million
-98,255 Reduced 16.28%
505,256 $70.4 Million
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $16.9 Million - $18.8 Million
134,316 Added 28.63%
603,511 $84.4 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $9.59 Million - $11.5 Million
78,050 Added 19.95%
469,195 $60.6 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $24.8 Million - $29.2 Million
-204,050 Reduced 34.28%
391,145 $54 Million
Q2 2018

Aug 02, 2018

SELL
$119.4 - $131.76 $4.92 Million - $5.43 Million
-41,200 Reduced 6.47%
595,195 $72.2 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $9.15 Million - $10.8 Million
73,150 Added 12.99%
636,395 $81.6 Million
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $7.91 Million - $8.66 Million
-60,300 Reduced 9.67%
563,245 $78.7 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $28.2 Million - $29.5 Million
217,725 Added 53.65%
623,545 $81.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
405,820
405,820 $53.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.